3 services
Pricing and market access
We stay with you as clinical and economic value is turned into durable market-access decisions
A product’s clinical value reaches patients in full only once it secures reimbursement approval. We translate clinical and economic evidence into the format payers expect.
3 services
Speaking the payer’s language
Our team is led by specialists who served for many years on the SGK Medical and Economic Evaluation Commission and TITCK scientific commissions, so we know the regulatory requirements first-hand.
- 03.1
Market access & reimbursement dossiers
SUT (Health Implementation Communiqué) applications, reimbursement and value dossier preparation, and management of the Reimbursement Commission process
- 03.2
Pharmacoeconomic analysis & modeling
Cost-effectiveness and budget-impact analyses, and decision-analytic modeling
- 03.3
Pharmaceutical pricing
Initial price applications, reference-price change applications and pricing strategy
Let’s talk about your access strategy
Write to us with your product’s indication and target price range and we will map out a route.
Services
- 01
Product R&D and regulatory affairs
From concept to dossier: scientific planning and a regulatory-compliant submission
- 02
Safety and toxicological assessment
Toxicological assessment, exposure limits, product safety and impurity evaluation
- 04
Mentor Ar-Ge Academy